← Back to Search

Behavioural Intervention

Accelerated TMS for Smoking Cessation in HIV/AIDS

N/A
Recruiting
Research Sponsored by Gopalkumar Rakesh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-60 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 1 of the study after intervention
Awards & highlights

Study Summary

This trialwill test whether a brain stimulation technique can reduce cravings in smokers with HIV/AIDS.

Who is the study for?
This trial is for adult smokers aged 18-60 living with HIV/AIDS, who can communicate in English and follow clinic rules. They must have low breath carbon monoxide levels, may use Suboxone if needed for opioid disorder, but should avoid other drugs. It's not for those with brain injury, metal in the head, seizures, bad reactions to TMS before, pregnant women or individuals with schizophrenia.Check my eligibility
What is being tested?
The study tests whether four sessions of accelerated Transcranial Magnetic Stimulation (TBS) can reduce cravings and attentional bias towards smoking cues compared to sham (fake) stimulation in people with HIV/AIDS who smoke.See study design
What are the potential side effects?
While side effects are not detailed here, common ones from TMS include headache or discomfort at the stimulation site. There might be a risk of seizure although it's rare.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 1 of the study after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and on day 1 of the study after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Craving for cigarettes
Gaze Fixation on Smoking Cues
Secondary outcome measures
Functional connectivity changes

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: TBS (Theta burst stimulation)Active Control1 Intervention
Four sessions of TBS in one day
Group II: Sham TMSPlacebo Group1 Intervention
Four sessions of sham TMS

Find a Location

Who is running the clinical trial?

Gopalkumar RakeshLead Sponsor
3 Previous Clinical Trials
79 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,583 Total Patients Enrolled

Media Library

Accelerated Transcranial Magnetic Stimulation (TMS) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05295953 — N/A
Tobacco Smoking Research Study Groups: TBS (Theta burst stimulation), Sham TMS
Tobacco Smoking Clinical Trial 2023: Accelerated Transcranial Magnetic Stimulation (TMS) Highlights & Side Effects. Trial Name: NCT05295953 — N/A
Accelerated Transcranial Magnetic Stimulation (TMS) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05295953 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this clinical exploration?

"This medical trial is searching for 60 individuals aged 18-60 who use tobacco regularly. To be eligible, applicants must comply with the following conditions: they should be signed up at Bluegrass Clinic and able to comprehend English; adhere to general regulations of said clinic; abstain from substances other than Suboxone; exhale breath containing less than 5 parts per million (ppm) carbon monoxide on day of study and have stabilized buprenorphine maintenance if there is a co-morbid opioid abuse issue."

Answered by AI

How many individuals are enrolled in this research endeavor?

"Affirmative. According to clinicaltrials.gov, this research is actively searching for volunteers. The study was initially posted on April 1st 2022 and has been updated as recently as November 7th 2022. A total of 60 participants are required from 2 sites."

Answered by AI

Is this research protocol considering elderly participants?

"This medical experiment is only accommodating participants between the ages of 18 and 60. There are 132 clinical studies available for minors, while elders may choose from 441 different trials."

Answered by AI

Are there currently any openings in this research endeavor?

"Yes, the trial is still recruiting patients. Data hosted on clinicaltrials.gov notes that this medical project was first posted in April 2022 and revised most recently in November of the same year."

Answered by AI
~7 spots leftby Jul 2024